Arvee Laboratories (India) Limited

Arvee Laboratories (India) Limited (ARVEE) is a micro-cap Chemicals company valued at ₹249 crore operating in Specialty Chemicals on the NSE and BSE.

Recent price move

Arvee Laboratories (India) Limited last traded at ₹230.96, up 2.24% on the day.

Recent developments

On 2026-06-30, the company reported its latest quarter results, showing a significant rebound in both revenue and net profit compared to the year-ago period. The company has not paid any dividends despite reporting profits.

Financial performance

The company's annual revenue fell 18.1% year-over-year, but net profit rose 17.7% due to improved margins. The latest quarter saw revenue surge 130.3% compared to the same quarter a year earlier, with net profit jumping 894.1% to ₹2 crore.

Valuation multiples

The stock trades at 100.9 times earnings, 6.37 times book value.

Things to watch

The company's revenue has declined over the past three years, with a compound annual growth rate of -19.9%. Profitability has also been volatile, with a 5-year profit CAGR of -1.1%. The stock is 26.0% below its 52-week high, and the company has not distributed any dividends to shareholders.

Where it stands

Arvee Laboratories India Ltd has shown a strong recovery in the latest quarter, with revenue and net profit both rising sharply compared to the same period a year earlier. However, the company's long-term revenue and profit growth has been negative, and it has not paid any dividends. The stock is currently 26.0% below its 52-week high.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.